Company Filing History:
Years Active: 2007
Title: Mike Nesheim: Innovator in Medical Diagnostics
Introduction
Mike Nesheim is a notable inventor based in Kingston, CA. He has made significant contributions to the field of medical diagnostics, particularly in the detection of lipoprotein-acute phase protein complexes. His innovative approach has the potential to improve patient outcomes by predicting risks associated with various health conditions.
Latest Patents
Mike Nesheim holds a patent for a method that detects a lipoprotein-acute phase protein complex and predicts an increased risk of system failure or mortality. This method involves several steps, including adding reagents to a blood sample from a patient to form a complex of acute phase proteins and human lipoproteins. The process measures the formation of this complex over time, allowing for a time-dependent measurement profile to be derived. By determining the slope and total change in this profile, healthcare providers can diagnose conditions more effectively. A greater formation of the complex is correlated with an increased probability of death, making this invention crucial for timely medical interventions. He has 1 patent to his name.
Career Highlights
Mike is currently employed at bioMérieux, Inc., a company renowned for its commitment to improving public health through innovative diagnostic solutions. His work at bioMérieux has allowed him to apply his expertise in developing methods that enhance patient care and diagnostic accuracy.
Collaborations
Throughout his career, Mike has collaborated with talented professionals, including Timothy J. Fischer and Colin Downey. These collaborations have fostered an environment of innovation and have contributed to the advancement of medical diagnostics.
Conclusion
Mike Nesheim's contributions to the field of medical diagnostics exemplify the impact of innovation on healthcare. His patented method for detecting lipoprotein-acute phase protein complexes represents a significant advancement in predicting patient outcomes. Through his work at bioMérieux, he continues to influence the future of medical diagnostics.